OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.

The company’s first product- the InSpace™ System is indicated for Rotator Cuff syndrome as it alleviates pain in patients. The InSpace™ System has the CE mark and is commercially available in Europe. 

In the USA, the InSpace is an investigational device. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigations.

Company Growth (employees)
Caesarea, IL
Size (employees)
28 (est)
OrthoSpace was founded in 2009 and is headquartered in Caesarea, IL

OrthoSpace Office Locations

OrthoSpace has offices in Caesarea, Milano, Fribourg, Kiel and in 10 other locations
Caesarea, IL (HQ)
7 Khalamish St
Macquarie Park, AU
85 Waterloo Rd
Bengaluru, IN
24th Main Rd
Moskva, RU
1 Timiryazevskaya ul.
Agia Paraskevi, GR
533 Leof. Mesogeion
Warszawa, PL
87 aleja Wilanowska
Show all (14)

OrthoSpace Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$15 m

Latest funding size

$7 m

Time since last funding

12 months


OrthoSpace's latest funding round in December 2016 was reported to be $7 m. In total, OrthoSpace has raised $15 m

OrthoSpace's Web-traffic and Trends

OrthoSpace Company Life and Culture

You may also be interested in